Tom Pelphrey Hits 46% in Emmy Supporting Actor Race After 12-Point Surge
Pelphrey's price climbed from 34% to 46% in 72 hours with no confirmed catalyst, while Kalshi and Polymarket remain seven points apart on fair value.

Tom Pelphrey is nominated for Outstanding Supporting Actor in a Drama Series at the 2026 Primetime Emmy Awards for his portrayal of Robbie Prendergrast in HBO's Task, and over the past 72 hours his implied probability of winning has climbed from 34% to 46% across prediction markets. That 12-point move arrived without a new episode drop, a viral clip, or a fresh press tour. No confirmed catalyst explains it. The question now is whether bettors are identifying a real consolidation of support or merely filling a vacuum left by an unusually disorganized field.
Prediction-market view
Resolved Sep 14, 2027Final prices, venue by venue
This market settled on September 14, 2027, so nothing below is tradeable. These are the last prices each venue published before settlement, not live quotes.
Tom Pelphrey's Emmy Odds Surge to 46% for Supporting Actor in a Drama Series
The price gap between platforms tells part of the story. Kalshi currently lists Pelphrey at 49%, while Polymarket holds him at 42%, a seven-point spread that suggests the two buyer pools are not processing the same information at the same speed. When a spread that wide persists for more than a day, it usually means one platform's participants are reacting to sentiment (social media chatter, awards-blog picks) while the other is waiting for harder evidence. Neither platform has seen a sharp competitor rise to absorb the opposing share, which is why Pelphrey's number keeps drifting upward.
His period low sat at 32%, meaning his swing from trough to current price is actually 14 points. For context, Pelphrey's second career Emmy nomination (his first came for Ozark in 2022) is being priced like a frontrunner's. That is unusual for a performer who has never won.
Who Is Tom Pelphrey Actually Beating? The 2026 Supporting Actor Drama Field
A 46% implied probability sounds commanding until you remember what it means: the market still gives Pelphrey a 54% chance of losing. The remaining probability is scattered across the rest of the field, with no single competitor consolidating a counter-narrative. Billy Crudup, a name generating steady search interest around Emmy conversations, represents the kind of established competitor who could absorb late-breaking voter sentiment. Crudup already owns an Emmy (Outstanding Supporting Actor in a Drama Series for The Morning Show in 2020) and carries the repeat-winner credibility that often surfaces in final-round voting.
Task earned six total nominations, which means the show itself has institutional support from the Television Academy. But shared nominations can cut both ways: if the show fields multiple Supporting Actor contenders, internal vote-splitting could dilute Pelphrey's margins at precisely the moment he needs consolidation. The field's lack of a definitive second-place finisher is what allowed Pelphrey's price to rise this fast. It is also what makes the price fragile.
The Second-Nomination Underdog Story Driving Tom Pelphrey's Emmy Market Momentum
Without a performance catalyst, this move is narrative-driven. Bettors appear to be pricing a familiar Emmy arc: the performer who earned a first nomination, lost, returned with stronger material, and now carries the "it's his time" storyline. Pelphrey's personal profile amplifies the effect. His fiancée, Kaley Cuoco, has been publicly championing the nomination, posting a billboard featuring his name on Instagram and generating entertainment-press coverage that keeps his name in the conversation even when no new Task content is circulating.
Emmy voters have historically rewarded this pattern. Aaron Paul won for Breaking Bad on his second nomination. Billy Crudup won on his first, but the broader category favors performers whose moment aligns with voter recognition fatigue toward perennial nominees. The question is whether Pelphrey's narrative has reached that threshold or whether bettors are projecting it prematurely.
The Case Against Pelphrey at 46%
Here is the strongest reason to doubt this price: Pelphrey has exactly one prior nomination and zero wins. Emmy voters in the Supporting Actor drama category have, in recent cycles, defaulted to established names when the field feels uncertain. A 46% implied probability assigns Pelphrey nearly a coin-flip chance of winning, yet his body of Emmy-recognized work is thinner than several competitors who have accumulated multiple nominations or prior victories. If a late-breaking performance narrative emerges for any rival (a finale airing, a prestige-magazine profile, a SAG or Critics Choice precursor win) Pelphrey's price has significant room to contract. The 14-point swing from his period low means the market has already priced in optimism that has not been validated by any external event.
Additionally, the seven-point Kalshi-Polymarket spread signals that even current buyers disagree on fair value. When sophisticated bettors on one platform price an outcome seven points below the other, it often reflects skepticism about whether the move is durable. A price that rose this fast on sentiment alone can fall just as quickly if a competitor's campaign gains traction.
What Happens Next: Resolution and Key Dates
The 78th Primetime Emmy Awards are scheduled for September 14, 2026, giving the market roughly three more weeks to settle. Between now and then, the critical inputs will be precursor awards, late-season press coverage, and any final voter-targeting campaigns from rival nominees. Pelphrey's 46% makes him the market leader today, but with more than half the probability distributed across a fragmented field, the category remains genuinely open.
For live odds and movement across all nominees, see the full Outstanding Supporting Actor in a Drama Series prediction market.
Join our Discord for breaking news alerts, driven by real-time movements in prediction markets.
The story so far: Emmy winner: Outstanding Supporting Actor in a Drama Series
5 updates · Jul 14 – Sep 12
Free Trading Tools
View allCompare fees across Kalshi, Polymarket & PredictIt.
Find fair probabilities with the overround removed.
See if a trade has positive EV before you enter.
Convert American, decimal & implied probability.
Combined odds and payouts for multi-leg bets.
Your real take-home after fees and taxes.
